Back
Zenas BioPharma Vs. Bicara Therapeutics Industry Stock Comparison
Sell
29
ZBIO
Zenas BioPharma
Last Price:
11.98
Seasonality Move:
1.54%
Sell
20
BCAX
Bicara Therapeutics
Last Price:
18.08
Seasonality Move:
--
Sell
29
Zenas BioPharma (ZBIO)
is a Sell
Is Zenas BioPharma a Buy, Sell or Hold?
- The current Zenas BioPharma [ZBIO] share price is $12.00. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
- The current Bicara Therapeutics [BCAX] share price is $18.09. The Score for BCAX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BCAX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ZBIO Stock Price Chart
What is Zenas BioPharma's stock price today?
-
The Zenas BioPharma share price today is $12.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $18.09
The current trend is relatively stagnant and BCAX is experiencing slight selling pressure.
ZBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.66 | Sell |
Relative Strength Index (14 RSI): | 28.62 | Sell |
Chaikin Money Flow: | 588416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.71 - 23.27) | Sell |
Bollinger Bands (100): | (8.72 - 18.66) | Sell |
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 30.37 | Sell |
Chaikin Money Flow: | -17151 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.11 - 24.31) | Sell |
Bollinger Bands (100): | ( - ) | Buy |
ZBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.94 | Sell |
20-day SMA: | 18.48 | Sell |
50-day SMA: | 17.37 | Sell |
200-day SMA: | 13.21 | Sell |
8-day EMA: | 14.43 | Sell |
20-day EMA: | 17.05 | Sell |
50-day EMA: | 16.9 | Sell |
200-day EMA: | 14.22 | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.65 | Sell |
20-day SMA: | 22.12 | Sell |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 19.51 | Sell |
20-day EMA: | 20.67 | Sell |
50-day EMA: | 17.42 | Buy |
200-day EMA: | 7.31 | Buy |
Zenas BioPharma Earnings Growth & ZBIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $2.84 per share.
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.26 per share.
Zenas BioPharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bicara Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |